Reversal effect of solanine on multidrug-resistance of leukemia K562/ADR cells and its mechanism / 肿瘤

ABSTRACT

Objective: To investigate the effect of solanine on multidrug resistance of leukemia K562/ADR cells, and to explore its mechanism. Methods: K562/ADR cells were treated with different concentrations (5-40 μg/mL) of solanine alone or in combination with doxorubicin (DOX) for 24 h. The intracellular toxicity and DOX-sensitization effect of solanine were detected by CCK-8 assay. The cell-associated mean fluorescence intensity of DOX was detected by FCM method. The expressions of multidrug resistance-associated protein 1 (MRP1), c-Jun NH2-terminal kinase (JNK), and phosphorylated JNK (p-JNK) were determined by Western blotting. Results: Solanine at non-toxic doses (5 and 10 μg/mL) significantly enhanced the cytotoxicity of DOX (both P < 0.05), and significantly increased the mean fluorescence intensity of DOX in K562/ADR cells in a dose-dependent manner (both P < 0.05). After treatment with 5 and 10 μg/mL solanine, the expression levels of MRP1 and p-JNK proteins were significantly decreased (all P < 0.05) in K562/ADR cells. Conclusion: Solanine can reverse multidrug resistance of K562/ADR cells in vitro. The mechanism may be related to blocking JNK signaling pathway and downregulating MRP1 expression.